Metabolife Personal Injury Settlement Includes $56 Million Fund For Ephedra Claims
Brown Rudnick Berlack Israels LLP reached a settlement against Ephedra manufacturer and distributor Metabolife. The $56 million personal injury settlement will be distributed to non-insured and under-insured tort claimants.
Metabolife now known as MII Liquidation filed for Chapter 11 bankruptcy in June 2005 after the FDA banned the Ephedra product in 2004. The personal injury settlement includes a plan to liquidate Metabolife's creditors as well as settle the numerous worldwide tort claims against the company.